Amel Chaabane
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
- Pharmacology top 5%
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Pharmacology 34
- Drug-Induced Adverse Reactions 32
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Karim Aouam (63 shared papers)Nadia Ben Fredj (51 shared papers)Naceur A. Boughattas (31 shared papers)Naceur A. Boughattas (18 shared papers)M. Chakroun (7 shared papers)Emna Kerkeni (8 shared papers)Kamel Monastiri (2 shared papers)Hichem Belhadjali (5 shared papers)
- Journals
- British Journal of Clinical Pharmacology (6 papers)The Pharmacogenomics Journal (5 papers)Diabetes & Metabolism (4 papers)The Journal of Clinical Pharmacology (4 papers)Clinical and Translational Allergy (3 papers)
- Partner nations
- TunisiaFranceNetherlands
In The Last Decade
Amel Chaabane
67 papers receiving 528 citations
Peers
Comparison fields: 5 of 88
- Transplantation 76
- Pharmacology 228
- Toxicology 34
- Pharmacology 62
- Dermatology 51
Countries citing papers authored by Amel Chaabane
This map shows the geographic impact of Amel Chaabane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amel Chaabane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amel Chaabane more than expected).
Fields of papers citing papers by Amel Chaabane
This network shows the impact of papers produced by Amel Chaabane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amel Chaabane. The network helps show where Amel Chaabane may publish in the future.
Co-authors
The 25 scholars most cited alongside Amel Chaabane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 37 | |
| 2 | 2015 | 36 | |
| 3 | 2016 | 34 | |
| 4 | 2019 | 32 | |
| 5 | 2007 | 29 | |
| 6 | 2009 | 24 | |
| 7 | 2008 | 23 | |
| 8 | 2023 | 18 | |
| 9 | 2013 | 17 | |
| 10 | 2011 | 15 | |
| 11 | 2011 | 15 | |
| 12 | 2014 | 14 | |
| 13 | 2021 | 14 | |
| 14 | 2020 | 13 | |
| 15 | 2020 | 11 | |
| 16 | 2019 | 10 | |
| 17 | 2013 | 9 | |
| 18 | 2019 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2008 | 8 |
About Amel Chaabane
Amel Chaabane is a scholar working on Pharmacology, Infectious Diseases, Transplantation, Surgery and Dermatology, having authored 73 papers that have together received 550 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (32 papers), Renal Transplantation Outcomes and Treatments (9 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers), Urticaria and Related Conditions (5 papers), Contact Dermatitis and Allergies (5 papers), Pharmacological Effects and Toxicity Studies (5 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Transplantation (76 citations), Pharmacology (228 citations), Toxicology (34 citations), Pharmacology (62 citations) and Dermatology (51 citations). Amel Chaabane has collaborated with scholars based in Tunisia, France and Netherlands. Frequent co-authors include Karim Aouam, Nadia Ben Fredj, Naceur A. Boughattas, Naceur A. Boughattas, M. Chakroun, Emna Kerkeni, Kamel Monastiri, Hichem Belhadjali, Souad Abderafi and Leïla Njim. Their work appears in journals such as British Journal of Clinical Pharmacology, The Pharmacogenomics Journal, Diabetes & Metabolism, The Journal of Clinical Pharmacology and Clinical and Translational Allergy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.